Huang, C.-Y.; Cheng, M.; Lee, N.-R.; Huang, H.-Y.; Lee, W.-L.; Chang, W.-H.; Wang, P.-H.
Comparing Paclitaxel–Carboplatin with Paclitaxel–Cisplatin as the Front-Line Chemotherapy for Patients with FIGO IIIC Serous-Type Tubo-Ovarian Cancer. Int. J. Environ. Res. Public Health 2020, 17, 2213.
https://doi.org/10.3390/ijerph17072213
AMA Style
Huang C-Y, Cheng M, Lee N-R, Huang H-Y, Lee W-L, Chang W-H, Wang P-H.
Comparing Paclitaxel–Carboplatin with Paclitaxel–Cisplatin as the Front-Line Chemotherapy for Patients with FIGO IIIC Serous-Type Tubo-Ovarian Cancer. International Journal of Environmental Research and Public Health. 2020; 17(7):2213.
https://doi.org/10.3390/ijerph17072213
Chicago/Turabian Style
Huang, Chen-Yu, Min Cheng, Na-Rong Lee, Hsin-Yi Huang, Wen-Ling Lee, Wen-Hsun Chang, and Peng-Hui Wang.
2020. "Comparing Paclitaxel–Carboplatin with Paclitaxel–Cisplatin as the Front-Line Chemotherapy for Patients with FIGO IIIC Serous-Type Tubo-Ovarian Cancer" International Journal of Environmental Research and Public Health 17, no. 7: 2213.
https://doi.org/10.3390/ijerph17072213
APA Style
Huang, C.-Y., Cheng, M., Lee, N.-R., Huang, H.-Y., Lee, W.-L., Chang, W.-H., & Wang, P.-H.
(2020). Comparing Paclitaxel–Carboplatin with Paclitaxel–Cisplatin as the Front-Line Chemotherapy for Patients with FIGO IIIC Serous-Type Tubo-Ovarian Cancer. International Journal of Environmental Research and Public Health, 17(7), 2213.
https://doi.org/10.3390/ijerph17072213